Endpoints News ٢٦ فبراير ٢٠٢٦ Viatris plans to lay off up to 10% of staff, discloses Indian factory fire
Endpoints News ٢٦ فبراير ٢٠٢٦ AtaiBeckley stock drops on Phase 2a data; Disc to refile rare disease drug
Endpoints News ٢٦ فبراير ٢٠٢٦ Protagonist to opt out of Takeda profit-sharing deal, will receive $400M in cash
Endpoints News ٢٦ فبراير ٢٠٢٦ Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer
Endpoints News ٢٦ فبراير ٢٠٢٦ OrbiMed jumps to number one on the top 100 list of biotech venture investors
Endpoints News ٢٦ فبراير ٢٠٢٦ Lilly's GLP-1 pill beats Novo’s in diabetes trial, has more side effects
Endpoints News ٢٥ فبراير ٢٠٢٦ Make way, Camzyos: Cytokinetics touts promising early launch for rival heart drug